• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺栓塞反应团队对急性肺栓塞的影响:系统评价和荟萃分析。

Impact of pulmonary embolism response teams on acute pulmonary embolism: a systematic review and meta-analysis.

机构信息

Dept of Thoracic Medicine and Surgery, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, USA

Both authors contributed equally.

出版信息

Eur Respir Rev. 2022 Jul 12;31(165). doi: 10.1183/16000617.0023-2022. Print 2022 Sep 30.

DOI:10.1183/16000617.0023-2022
PMID:35831010
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9724819/
Abstract

BACKGROUND

The impact of pulmonary embolism response teams (PERTs) on treatment choice and outcomes of patients with acute pulmonary embolism (PE) is still uncertain.

OBJECTIVE

To determine the effect of PERTs in the management and outcomes of patients with PE.

METHODS

PubMed, Embase, Web of Science, CINAHL, WorldWideScience and MedRxiv were searched for original articles reporting PERT patient outcomes from 2009. Data were analysed using a random effects model.

RESULTS

16 studies comprising 3827 PERT patients and 3967 controls met inclusion criteria. The PERT group had more patients with intermediate and high-risk PE (66.2%) compared to the control group (48.5%). Meta-analysis demonstrated an increased risk of catheter-directed interventions, systemic thrombolysis and surgical embolectomy (odds ratio (OR) 2.10, 95% confidence interval (CI) 1.74-2.53; p<0.01), similar bleeding complications (OR 1.10, 95% CI 0.88-1.37) and decreased utilisation of inferior vena cava (IVC) filters (OR 0.71, 95% CI 0.58-0.88; p<0.01) in the PERT group. Furthermore, there was a nonsignificant trend towards decreased mortality (OR 0.87, 95% CI 0.71-1.07; p=0.19) with PERTs.

CONCLUSIONS

The PERT group showed an increased use of advanced therapies and a decreased utilisation of IVC filters. This was not associated with increased bleeding. Despite comprising more severe PE patients, there was a trend towards lower mortality in the PERT group.

摘要

背景

肺栓塞反应团队(PERT)对急性肺栓塞(PE)患者治疗选择和结局的影响仍不确定。

目的

确定 PERT 在 PE 患者管理和结局中的作用。

方法

检索了 2009 年以来发表的关于 PERT 患者结局的原始文章,包括 PubMed、Embase、Web of Science、CINAHL、WorldWideScience 和 MedRxiv。使用随机效应模型进行数据分析。

结果

纳入了 16 项研究,共 3827 例 PERT 患者和 3967 例对照。与对照组(48.5%)相比,PERT 组中具有中高危 PE 的患者更多(66.2%)。荟萃分析显示,PERT 组接受导管定向介入治疗、全身溶栓和手术取栓的风险增加(比值比(OR)2.10,95%置信区间(CI)1.74-2.53;p<0.01),出血并发症相似(OR 1.10,95%CI 0.88-1.37),下腔静脉(IVC)滤器的使用率降低(OR 0.71,95%CI 0.58-0.88;p<0.01)。此外,PERT 组的死亡率呈下降趋势(OR 0.87,95%CI 0.71-1.07;p=0.19),但无统计学意义。

结论

PERT 组显示出更倾向于使用高级治疗方法,同时减少了 IVC 滤器的使用。这与增加出血无关。尽管 PERT 组患者的 PE 更严重,但死亡率呈下降趋势。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b27a/9724819/eb90178e03c1/ERR-0023-2022.02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b27a/9724819/653bb590999f/ERR-0023-2022.01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b27a/9724819/eb90178e03c1/ERR-0023-2022.02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b27a/9724819/653bb590999f/ERR-0023-2022.01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b27a/9724819/eb90178e03c1/ERR-0023-2022.02.jpg

相似文献

1
Impact of pulmonary embolism response teams on acute pulmonary embolism: a systematic review and meta-analysis.肺栓塞反应团队对急性肺栓塞的影响:系统评价和荟萃分析。
Eur Respir Rev. 2022 Jul 12;31(165). doi: 10.1183/16000617.0023-2022. Print 2022 Sep 30.
2
Catheter-directed therapies for the treatment of high risk (massive) and intermediate risk (submassive) acute pulmonary embolism.经导管治疗高危(大块)和中危(次大块)急性肺栓塞。
Cochrane Database Syst Rev. 2022 Aug 8;8(8):CD013083. doi: 10.1002/14651858.CD013083.pub2.
3
Do Pulmonary Embolism Response Teams for Acute Pulmonary Embolism Improve Outcomes? Insights from a Meta-analysis.急性肺栓塞的肺栓塞反应团队能否改善治疗结果?一项荟萃分析的见解
Am J Cardiol. 2025 Aug 15;249:71-82. doi: 10.1016/j.amjcard.2025.04.017. Epub 2025 Apr 20.
4
Antiplatelet agents for the treatment of deep venous thrombosis.抗血小板药物治疗深静脉血栓形成。
Cochrane Database Syst Rev. 2022 Jul 25;7(7):CD012369. doi: 10.1002/14651858.CD012369.pub2.
5
The use of Veno-arterial Extracorporeal Membrane Oxygenation (VA-ECMO) for Acute High Risk Pulmonary Embolism: A Systematic Review.静脉-动脉体外膜肺氧合(VA-ECMO)用于急性高危肺栓塞:一项系统评价
Curr Cardiol Rev. 2025;21(4):e1573403X339627. doi: 10.2174/011573403X339627241224085451.
6
A meta-analysis of outcomes of catheter-directed thrombolysis for high- and intermediate-risk pulmonary embolism.高、中危肺栓塞导管溶栓治疗结局的荟萃分析。
J Vasc Surg Venous Lymphat Disord. 2018 Jul;6(4):530-540. doi: 10.1016/j.jvsv.2018.03.010.
7
Vena caval filters for the prevention of pulmonary embolism.用于预防肺栓塞的腔静脉滤器
Cochrane Database Syst Rev. 2007 Jul 18(3):CD006212. doi: 10.1002/14651858.CD006212.pub2.
8
Interventions for implementation of thromboprophylaxis in hospitalized patients at risk for venous thromboembolism.对有静脉血栓栓塞风险的住院患者实施血栓预防的干预措施。
Cochrane Database Syst Rev. 2018 Apr 24;4(4):CD008201. doi: 10.1002/14651858.CD008201.pub3.
9
Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism.联合间歇性气动腿部压迫和药物预防预防静脉血栓栓塞症。
Cochrane Database Syst Rev. 2022 Jan 28;1(1):CD005258. doi: 10.1002/14651858.CD005258.pub4.
10
Non-pharmacological interventions for preventing delirium in hospitalised non-ICU patients.非 ICU 住院患者预防谵妄的非药物干预措施。
Cochrane Database Syst Rev. 2021 Nov 26;11(11):CD013307. doi: 10.1002/14651858.CD013307.pub3.

引用本文的文献

1
Endovascular management of intermediate-risk pulmonary embolism: evidence, outstanding questions, drivers of utilization, and the horizon.中危肺栓塞的血管内治疗:证据、未决问题、应用驱动因素及展望
Eur Heart J Open. 2025 Jun 4;5(3):oeaf071. doi: 10.1093/ehjopen/oeaf071. eCollection 2025 May.
2
Recent advances in risk stratification and treatment of acute pulmonary embolism.急性肺栓塞风险分层与治疗的最新进展
World J Cardiol. 2025 May 26;17(5):104983. doi: 10.4330/wjc.v17.i5.104983.
3
Rethinking Pulmonary Embolism Management with an Interventional Perspective.

本文引用的文献

1
Effect of a Multidisciplinary Pulmonary Embolism Response Team on Patient Mortality.多学科肺栓塞反应团队对患者死亡率的影响。
Am J Cardiol. 2021 Dec 15;161:102-107. doi: 10.1016/j.amjcard.2021.08.066.
2
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.PRISMA 2020 声明:系统评价报告的更新指南。
BMJ. 2021 Mar 29;372:n71. doi: 10.1136/bmj.n71.
3
Role of Pulmonary Embolism Response Team in patients with intermediate- and high-risk pulmonary embolism: a concise review and preliminary experience from China.
从介入角度重新思考肺栓塞的管理
J Clin Med. 2025 Apr 29;14(9):3085. doi: 10.3390/jcm14093085.
4
Association of pan-immune inflammation value with mortality in patients with pulmonary embolism: a cohort study.全免疫炎症值与肺栓塞患者死亡率的关联:一项队列研究
Sci Rep. 2025 Feb 24;15(1):6571. doi: 10.1038/s41598-025-90951-y.
5
Comorbidity profiles and pulmonary embolism risk assessment: Leveraging the Charlson Comorbidity Index for improved prognostication in a national data set.合并症概况与肺栓塞风险评估:利用查尔森合并症指数改善全国数据集的预后预测
Pulm Circ. 2024 Nov 7;14(4):e70010. doi: 10.1002/pul2.70010. eCollection 2024 Oct.
6
Approach to pulmonary embolism for frontline clinicians.一线临床医生对肺栓塞的诊疗方法
Singapore Med J. 2024 Sep 1;65(9):508-513. doi: 10.4103/singaporemedj.SMJ-2023-212. Epub 2024 Sep 6.
7
Evolution of Pulmonary Embolism Response Teams in the United States: A Review of the Literature.美国肺栓塞反应团队的发展:文献综述
J Clin Med. 2024 Jul 8;13(13):3984. doi: 10.3390/jcm13133984.
8
The association between lactate dehydrogenase to serum albumin ratio and in-hospital mortality in patients with pulmonary embolism: a retrospective analysis of the MIMIC-IV database.乳酸脱氢酶与血清白蛋白比值与肺栓塞患者院内死亡率的关联:对MIMIC-IV数据库的回顾性分析
Front Cardiovasc Med. 2024 Jun 19;11:1398614. doi: 10.3389/fcvm.2024.1398614. eCollection 2024.
9
From Trendelenburg to PERTs: Evolution in the Management of Massive Pulmonary Embolism.从特伦德伦伯格到 PERTs:大块肺栓塞治疗方法的演变。
Methodist Debakey Cardiovasc J. 2024 May 16;20(3):19-26. doi: 10.14797/mdcvj.1345. eCollection 2024.
10
The Obesity Mortality Paradox in Patients with Pulmonary Embolism: Insights from a Tertiary Care Center.肺栓塞患者中的肥胖死亡率悖论:来自三级医疗中心的见解
J Clin Med. 2024 Apr 19;13(8):2375. doi: 10.3390/jcm13082375.
肺栓塞反应小组在中高危肺栓塞患者中的作用:中国的简要综述与初步经验
J Geriatr Cardiol. 2020 Aug;17(8):510-518. doi: 10.11909/j.issn.1671-5411.2020.08.005.
4
Pulmonary Embolism Response Team activation during the COVID-19 pandemic in a New York City Academic Hospital: a retrospective cohort analysis.在纽约市一家学术医院的 COVID-19 大流行期间启用肺栓塞反应团队:一项回顾性队列分析。
J Thromb Thrombolysis. 2021 Feb;51(2):330-338. doi: 10.1007/s11239-020-02264-8.
5
Vancouver General Hospital Pulmonary Embolism Response Team (VGH PERT): initial three-year experience.温哥华总医院肺栓塞反应小组(VGH PERT):初步三年经验。
Can J Anaesth. 2020 Dec;67(12):1806-1813. doi: 10.1007/s12630-020-01790-6. Epub 2020 Aug 17.
6
Inferior Vena Cava Filters: Past, Present, and Future.下腔静脉滤器:过去、现在和未来。
Chest. 2020 Dec;158(6):2579-2589. doi: 10.1016/j.chest.2020.08.002. Epub 2020 Aug 11.
7
Adoption of a dedicated multidisciplinary team is associated with improved survival in acute pulmonary embolism.采用专门的多学科团队与急性肺栓塞患者的存活率提高相关。
Respir Res. 2020 Jun 22;21(1):159. doi: 10.1186/s12931-020-01422-z.
8
Value-based assessment of implementing a Pulmonary Embolism Response Team (PERT).基于价值的肺栓塞反应团队(PERT)实施评估。
J Thromb Thrombolysis. 2021 Jan;51(1):217-225. doi: 10.1007/s11239-020-02188-3.
9
Effects of a Consensus-Based Pulmonary Embolism Treatment Algorithm and Response Team on Treatment Modality Choices, Outcomes, and Complications.基于共识的肺栓塞治疗算法和反应团队对治疗方式选择、结局和并发症的影响。
Clin Appl Thromb Hemost. 2020 Jan-Dec;26:1076029620928420. doi: 10.1177/1076029620928420.
10
Changes in Care for Acute Pulmonary Embolism Through A Multidisciplinary Pulmonary Embolism Response Team.通过多学科肺栓塞反应团队改变急性肺栓塞的护理。
Am J Med. 2020 Nov;133(11):1313-1321.e6. doi: 10.1016/j.amjmed.2020.03.058. Epub 2020 May 19.